Norihisa Ootake

Tissue factor pathway inhibitor 2: A potential diagnostic marker for discriminating benign from malignant ovarian tumors

R. Kawaguchi, F. Kimura, Yuki Yamada, 2022, The journal of obstetrics and gynaecology research.

Tissue Factor Pathway Inhibitor 2: A Novel Biomarker for Predicting Asymptomatic Venous Thromboembolism in Patients with Epithelial Ovarian Cancer

R. Kawaguchi, Yuki Yamada, Ryuta Miyake, 2022, Gynecologic and Obstetric Investigation.

Tissue factor pathway inhibitor 2 as a serum marker for diagnosing asymptomatic venous thromboembolism in patients with epithelial ovarian cancer and positive D-dimer results.

Hiroshi Kobayashi, R. Kawaguchi, Yuki Yamada, 2021, Molecular and clinical oncology.